贵州医科大学学报

2018, v.43;No.214(07) 851-854

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

埃索美拉唑联合莫沙必利对食管炎部分食管动力学指标及胃蛋白酶原水平的影响
Effect of Esomeprazole Combined with Mosapride on Partial Esophageal Dynamics and Propepsin Levels in Oesophagitis Patients

李福强;杨杰;姚怡然;刘太阳;肖源;余劲松;
LI Fuqiang;YANG Jie;YAO Yiran;LIU Taiyang;XIAO Yuan;YU Jinsong;Guizhou Medical University Affiliated Hospital;

摘要(Abstract):

目的:研究埃索美拉唑联合莫沙必利对食管炎部分食管动力学指标及胃蛋白酶原水平的影响。方法:86例食管炎患者均分为观察组和对照组,对照组患者给予奥美拉唑肠溶胶囊联合多潘立酮治疗,观察组患者给予埃索美拉唑肠溶胶囊联合枸橼酸莫沙必利片治疗;治疗8周时评价2组患者的临床治疗效果,比较治疗前后2组患者的食管括约肌压力、卧位反流时间比及立位反流时间比、胃蛋白酶原Ⅰ(PGⅠ)及胃蛋白酶原Ⅱ(PGⅡ)水平。结果:观察组患者治疗总有效率(93.02%)高于对照组(79.07%),差异有统计学意义(P<0.05);治疗后,2组患者的食管括约肌压力较治疗前均升高、平均卧位反流时间比、立位反流时间比、PGⅠ、PGⅡ较治疗前均降低(P<0.05),观察组各指标的改善幅度均大于对照组(P<0.05)。结论:埃索美拉唑联合莫沙必利联合治疗食管炎的疗效优于奥美拉唑肠溶胶囊联合多潘立酮,能有效改善患者的部分食管动力学及胃蛋白酶原指标。
Objective: To study the effect of esomeprazole combined with mosapride on esophageal dynamics and propepsin levels of oesophagitis patients. Methods: 86 cases of esophagitis patients in our hospital were average divided into observation group( 43 cases) and control group( 43 cases).The control group patients were treated with omeprazole combined with domperidone and colloidal bismuth pectin capsules while the observation group patients were treated with esomeprazole enteric coated capsules combined with Moxapride citrate tablets and colloidal bismuth pectin capsules. The clinical treatment effect of 2 groups of patients were assessed after eight weeks,patients of the two groups before and after treatment are compared with Esophageal sphincter pressure,horizontal reflow time ratio and vertical reflow time ratio and levels of propepsin I( PG I) and propepsin II( PG II). Results:The total effective rate( 93. 02%) of the observation group of patients with clinical treatment was higher than that of control group( 79. 07%),the difference was statistically significant( P < 0. 05). Esophageal sphincter pressure of 2 groups of patients both increased after treatment more than before treatment( P < 0. 05),the average Recumbent reflux time ratio and Vertical reversal time ratio,PG I and PG II decreased compared with before treatment( P < 0. 05),but the amplitude of the index of the observation group was improved more greatly than that of the control group( P < 0. 05). Conclusion:Esomeprazole combined with mosapride can make better effect on esophagitis than omeprazole combined with domperidone and effectively improve the patients with esophageal motility index and propepsin indexes.

关键词(KeyWords): 食管炎,消化性;埃索美拉唑;莫沙必利;奥美拉唑;多潘立酮;食管动力学;胃蛋白酶原
esophagitis,digestibility;esomeprazole;mosapride;omeprazole;domperidone;esophageal dynamics;pepsinogen

Abstract:

Keywords:

基金项目(Foundation): 贵阳医学院附院博士基金项目

作者(Author): 李福强;杨杰;姚怡然;刘太阳;肖源;余劲松;
LI Fuqiang;YANG Jie;YAO Yiran;LIU Taiyang;XIAO Yuan;YU Jinsong;Guizhou Medical University Affiliated Hospital;

Email:

DOI: 10.19367/j.cnki.1000-2707.2018.07.024

参考文献(References):

文章评论(Comment):

序号(No.) 时间(Time) 反馈人(User) 邮箱(Email) 标题(Title) 内容(Content)
反馈人(User) 邮箱地址(Email)
反馈标题(Title)
反馈内容(Content)
扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享